Search results for "Agoni"

showing 10 items of 2493 documents

One-year renal and cardiac effects of bisoprolol versus losartan in recently diagnosed hypertensive patients: a randomized, double-blind study.

2009

BACKGROUND AND OBJECTIVES: Hypertension is a significant cause of chronic renal injury and its effective treatment is capable of reducing the rate of renal failure. beta-Adrenoceptor antagonists (beta-blockers) have been reported to induce a deterioration in renal function, while several data have indicated a renoprotective effect of treatment with the angiotensin II type 1 receptor antagonist losartan. Previous studies of the interaction between the selective beta(1)-blocker bisoprolol and kidney function were performed only for short- and medium-term periods. The aim of this study was to compare the antihypertensive efficacy and renal and cardiac haemodynamic effects of bisoprolol with th…

AdultMalemedicine.medical_specialtyTime Factorsmedicine.drug_classRenal functionHemodynamicsEssential hypertensionKidneyKidney Function TestsLosartanlaw.inventionRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineBisoprololHumansPharmacology (medical)Antihypertensive Agentshypertension losartanbisiprololbusiness.industryHeartGeneral MedicineMiddle AgedReceptor antagonistmedicine.diseaseAngiotensin IILosartanBisoprololHeart Function TestsHypertensionCardiologyFemalebusinessmedicine.drug
researchProduct

Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial.

2016

AdultMalemedicine.medical_specialtyUrticariaImmunologyTreatment outcomePlacebo-controlled studyMEDLINEDrug ResistanceHistamine AntagonistsOmalizumabOmalizumablaw.invention030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineRandomized controlled trialDouble-Blind MethodlawInternal medicineAnti-Allergic AgentsImmunology and AllergyMedicineHumansbusiness.industryMiddle AgedSymptomatic dermographismTreatment Outcome030228 respiratory systemMulticenter studyFemalebusinessmedicine.drugThe Journal of allergy and clinical immunology
researchProduct

Enhancement by vasopressin of adrenergic responses in human mesenteric arteries.

1997

Vasopressin not only acts directly on blood vessels through V1-receptor stimulation but also may modulate adrenergic-mediated responses in animal experiments in vitro and in vivo. The aim of the present study was to investigate whether subpressor concentrations of vasopressin could modify the constrictor responses to norepinephrine and electrical stimulation of the perivascular nerves in human mesenteric arteries. Human mesenteric artery rings (3-3.5 mm long, 0.8-1.2 mm OD) were obtained from 38 patients undergoing abdominal operations. The arterial rings were suspended in organ bath chambers for isometric recording of tension. Vasopressin (3 x 10(-11) M) enhanced the contractions elicited…

AdultMalemedicine.medical_specialtyVasopressinPhysiologyVasopressinsNeuropeptideAdrenergicStimulationIn Vitro TechniquesMuscle Smooth VascularPotassium ChlorideNorepinephrine (medication)Calcium ChlorideNorepinephrineHormone AntagonistsNifedipinePhysiology (medical)Internal medicinemedicineHumansMesenteric arteriesAgedbusiness.industryMiddle AgedElectric StimulationMesenteric ArteriesArginine Vasopressinmedicine.anatomical_structureEndocrinologyCatecholamineFemaleCardiology and Cardiovascular MedicinebusinessOmentummedicine.drugMuscle ContractionThe American journal of physiology
researchProduct

Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study.

2011

Abstract The safest duration of anticoagulation after idiopathic deep vein thrombosis (DVT) is unknown. We conducted a prospective study to assess the optimal duration of vitamin K antagonist (VKA) therapy considering the risk of recurrence of thrombosis according to residual vein thrombosis (RVT). Patients with a first unprovoked DVT were evaluated for the presence of RVT after 3 months of VKA administration; those without RVT suspended VKA, while those with RVT continued oral anticoagulation for up to 2 years. Recurrent thrombosis and/or bleeding events were recorded during treatment (RVT group) and 1 year after VKA withdrawal (both groups). Among 409 patients evaluated for unprovoked DVT…

AdultMalemedicine.medical_specialtyVitamin Kmedicine.drug_classDeep veinHemorrhageDrug Administration ScheduleSettore MED/15 - Malattie Del SangueRecurrenceRisk Factorsdeep vein thrombosis (DVT)Residual vein thrombosismedicineHumansProspective Studiesdeep vein thrombosis (DVT); vitamin K antagonist (VKA) therapy; Residual vein thrombosisProspective cohort studyAgedUltrasonographyVenous Thrombosisbusiness.industryAcenocoumarolAnticoagulantsHematologyVenous ThromboembolismVitamin K antagonistMiddle Agedmedicine.diseaseThrombosisConfidence intervalSurgeryClinical trialVein thrombosisvitamin K antagonist (VKA) therapymedicine.anatomical_structureLower ExtremityRelative riskFemaleWarfarinbusiness
researchProduct

Clinical Problem Solving and Using New Paths in the Laboratory: Learning from Case Studies.

2020

AbstractThree selected casuistic studies of individual patient problems from my long-standing professional experience are presented. I intend to highlight the potential contribution of case studies, including new approaches of laboratory investigation, for the advancement of pathophysiological knowledge and would encourage to “rehabilitate” the low academic profile generally attributed to “case reports.”

AdultMalemedicine.medical_specialtybusiness.industrymedicine.drug_classThrombotic thrombocytopenic purpuraMEDLINEHematology030204 cardiovascular system & hematologyVitamin K antagonistmedicine.disease03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisMedicineHumansFemalebusinessIntensive care medicineLaboratoriesProblem SolvingHamostaseologie
researchProduct

Misclassification of subjects with insulin resistance and associated cardiovascular risk factors by homeostasis model assessment index. Utility of a …

2009

Different methods are available for assessing insulin sensitivity in the fasting state. However, insulin resistance (IR) is initially a postprandial disturbance; and usually, when basal (fasting) disturbance appears, the process has been in progress for some time. Our aim was to investigate if a postprandial measurement, performing an oral glucose tolerance test (OGTT), is more sensitive than fasting values. We wished to identify early IR states in healthy, nonobese individuals and ascertain if this situation was associated with other cardiovascular risk factors. A total of 90 nonobese, nondiabetic, and nonsmoker individuals were studied. They were divided into 3 groups according to IR stat…

AdultMalemedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismPopulationBlood PressureModels BiologicalSensitivity and SpecificityBody Mass IndexEndocrinologyInsulin resistanceInternal medicinemedicineHomeostasisHumansInsulinDiagnostic ErrorsRisk factoreducationeducation.field_of_studyGlucose tolerance testmedicine.diagnostic_testbusiness.industrynutritional and metabolic diseasesGlucose Tolerance TestMiddle AgedPostprandial Periodmedicine.diseaseEndocrinologyBlood pressurePostprandialBasal (medicine)Cardiovascular DiseasesFemaleInsulin ResistanceWaist CircumferencebusinessBody mass indexhormones hormone substitutes and hormone antagonistsMetabolism
researchProduct

Childhood neglect and parental care perception in cocaine addicts: Relation with psychiatric symptoms and biological correlates

2009

Childhood neglect and poor child–parent relationships have been reported to increase substance use disorders susceptibility. Stressful environmental factors, including emotional neglect, could affect individual personality traits and mental health, possibly inducing stable changes in hypothalamic–pituitary–adrenal (HPA) axis and brain mono-amine function, in turn involved in addictive behavior vulnerability. Therefore, we decided to investigate homovanillic (HVA) and prolactin (PRL) plasma levels, as expression of possible changes in dopamine function, ACTH and cortisol plasma levels, as measures of HPA axis function, and concomitant psychiatric symptoms profile in abstinent cocaine a…

AdultMalemedicine.medical_specialtyendocrine systemAdolescentHydrocortisoneCognitive Neurosciencemedia_common.quotation_subjectPoison controlHostilityAdrenocorticotropic hormonePSYCHIATRIC SYMPTOMSNeglectPROLACTIN (PRL)Cocaine-Related DisordersYoung AdultBehavioral NeuroscienceAdrenocorticotropic HormoneSurveys and QuestionnairesElectrochemistrymedicineHumansChild AbuseChildPsychiatryChromatography High Pressure LiquidChildhood neglect parental care cocaine addictionRetrospective Studiesmedia_commonParentingMental DisordersAddictionPsychiatric assessmentHomovanillic Acidmedicine.diseaseProlactinNeuropsychology and Physiological PsychologyHOMOVANILLIC ACID (HVA)NEGLECTChild PreschoolRegression AnalysisFemalemedicine.symptomAddictive behaviorPsychologyCOCAINEAnxiety disorderhormones hormone substitutes and hormone antagonistsPersonality
researchProduct

Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemia

1993

It was the aim of this study to investigate the antileukemic activities of recombinant interferon beta (rIFN beta) in chronic-phase CML in vitro and in vivo. Nine patients in the early chronic-phase of CML were treated in a phase-II trial with escalating doses of rIFN beta. In parallel, antiproliferative and immunomodulatory activities of rIFN beta and rIFN alpha 2b were studied in vitro. rIFN beta exhibited a significantly higher antiproliferative activity on hematopoietic progenitor cells of CML patients in vitro than rIFN alpha 2b. In contrast, only very limited clinical antileukemic efficacy of rIFN beta was observed. None of the patients achieved a complete or partial hematologic respo…

AdultMalemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentAlpha (ethology)Interferon alpha-2PharmacologyNeopterinIn vivoInternal medicineHumansMedicineBeta (finance)AgedHematologyDose-Response Relationship Drugbusiness.industryInterferon-alphaInterferon-betaHematologyGeneral MedicineImmunotherapyMiddle AgedReceptor antagonistmedicine.diseaseBiopterinRecombinant ProteinsCytokineGenesLeukemia Myeloid Chronic-PhaseImmunologyFemaleInterferonsbeta 2-MicroglobulinbusinessChronic myelogenous leukemiaAnnals of Hematology
researchProduct

Risperidone in the Treatment of Disorders with a combined Psychotic and Depressive Syndrome - A Functional Approach

1992

In vitro receptor-binding profiles and in vivo pharmacological studies have shown risperidone to be a potent mixed serotonin-S2 dopamine-D2-like receptor antagonist. While anti-D2 activity may relate to the antipsychotic potency of neuroleptic drugs, an antidepressive efficacy of substances with anti-S2 activity has been suggested. In an open pilot-study, ten patients with schizodepressive disorders or a DSM-III-R diagnosis of psychotic major depressive episodes were treated with risperidone (2-10 mg/d) for six weeks. Weekly psychopathological evaluation was performed, including BPRS, SANS, SAPS, VAS scales, and AIMS and UKU for the assessment of side-effects. Generally, the psychotic syndr…

AdultMalemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentPiperidinesInternal medicineHumansMedicinePotencyPharmacology (medical)AntipsychoticDepression (differential diagnoses)AgedPsychiatric Status Rating ScalesDepressive DisorderRisperidonebusiness.industryDopamine antagonistIsoxazolesSyndromeGeneral MedicineMiddle AgedRisperidoneReceptor antagonistBiperidenPsychiatry and Mental healthPsychotic DisordersAnesthesiaFemalebusinessAntipsychotic AgentsPsychopathologymedicine.drugPharmacopsychiatry
researchProduct

Therapeutic Drug Monitoring of the Antidepressant Mirtazapine and Its N-Demethylated Metabolite in Human Serum

2004

Mirtazapine is a novel antidepressant that acts by enhancing serotonergic and noradrenergic neurotransmission. Because very little is known about serum concentrations in relation to clinical effects, the use of therapeutic drug monitoring is so far unclear. A rapid automated HPLC method with fluorescence detection was developed for routine quantification of mirtazapine and its demethylated metabolite N-desmethylmirtazapine in human serum. The precision of the method was suitable because the day-to-day (n = 7) coefficient of variation (CV) of mirtazapine was 9.8, 4.2, and 5.1% for concentrations of 10, 40, and 80 ng/mL, respectively, and the CV for N-desmethylmirtazapine were 11.6, 10.3, and…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentMetaboliteCoefficient of variationMirtazapineMirtazapineMianserinPharmacologySensitivity and Specificitychemistry.chemical_compoundInternal medicinemedicineHumansPharmacology (medical)AmisulprideAntipsychoticChromatography High Pressure LiquidAgedPharmacologySertralinemedicine.diagnostic_testbusiness.industryMiddle AgedEndocrinologychemistryTherapeutic drug monitoringHistamine H1 AntagonistsAntidepressantFemaleDrug Monitoringbusinessmedicine.drugTherapeutic Drug Monitoring
researchProduct